Vaughan Elizabeth M, Johnston Craig A, Arlinghaus Katherine R, Hyman David J, Foreyt John P
Department of Medicine, Baylor College of Medicine, 1504 Taub Loop, 2 RM-81-001 a-f. BCM 285, Houston, TX, United States.
Department of Health, University of Houston, 3855 Holman Street, Houston, TX, United States.
Curr Diabetes Rev. 2019;15(5):372-381. doi: 10.2174/1573399814666181112145910.
Prior studies have supported the efficacy of diabetes group visits. However, the benefit of diabetes group visits for low-income and underserved individuals is not clear. The purpose of this study was to conduct a narrative review in order to clarify the efficacy of diabetes group visits in low-income and underserved settings.
The authors performed a narrative review, categorizing studies into nonrandomized and randomized.
A total of 14 studies were identified. Hemoglobin A1c was the most commonly measured outcome, which improved for the majority of group visit participants. Preventive care showed consistent improvement for intervention arms. There were several other study outcomes including metabolic (i.e., blood pressure), behavioral (i.e., exercise), functional (i.e., quality of life), and system-based (i.e., cost).
Diabetes group visits for low-income and underserved individuals resulted in superior preventive care but the impact on glycemic control remains unclear.
先前的研究支持糖尿病小组就诊的疗效。然而，糖尿病小组就诊对低收入和服务不足人群的益处尚不清楚。本研究的目的是进行一项叙述性综述，以阐明糖尿病小组就诊在低收入和服务不足环境中的疗效。
作者进行了一项叙述性综述，将研究分为非随机和随机研究。
共确定了14项研究。糖化血红蛋白是最常测量的结果，大多数小组就诊参与者的糖化血红蛋白有所改善。干预组的预防保健显示出持续改善。还有其他一些研究结果，包括代谢（即血压）、行为（即运动）、功能（即生活质量）和基于系统的（即成本）。
针对低收入和服务不足人群的糖尿病小组就诊带来了更好的预防保健，但对血糖控制的影响仍不清楚。
